The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: A Literature Review
Diabetic individuals are considered a vulnerable population during the COVID-19 Pandemic, and several studies noted worse outcomes, including death, among those who get infected. Diabetic emergencies, such as ketoacidosis (DKA), are common and potentially life-threatening conditions in uncontrolled...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2021-11-01
|
| Series: | The Journal of Critical Care Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/jccm-2021-0024 |
| _version_ | 1797422212590862336 |
|---|---|
| author | Tilinca Mariana Cornelia Gliga Maximilian Cosma Varga Andreea |
| author_facet | Tilinca Mariana Cornelia Gliga Maximilian Cosma Varga Andreea |
| author_sort | Tilinca Mariana Cornelia |
| collection | DOAJ |
| description | Diabetic individuals are considered a vulnerable population during the COVID-19 Pandemic, and several studies noted worse outcomes, including death, among those who get infected. Diabetic emergencies, such as ketoacidosis (DKA), are common and potentially life-threatening conditions in uncontrolled patients. While the pathophysiological background of the relationship between COVID-19 and DKA is not fully understood, early reports available so far indicate that patients with pre-existing diabetes who get infected with the SARS-CoV 2 virus are at higher risk of DKA. It was also suggested that DKA is a poor prognostic sign for infected patients, these being at higher risk of developing worse forms of COVID-19 disease and having high mortality. Therefore, healthcare personnel dealing with such patients face a considerable challenge, as the correct and safe emergency management of such cases is far from established. This article aimed to conduct a study that reviews the current published data available about patients with DKA and COVID-19. |
| first_indexed | 2024-03-09T07:28:58Z |
| format | Article |
| id | doaj.art-24237396815d4d49830827ceb177d582 |
| institution | Directory Open Access Journal |
| issn | 2393-1817 |
| language | English |
| last_indexed | 2024-03-09T07:28:58Z |
| publishDate | 2021-11-01 |
| publisher | Sciendo |
| record_format | Article |
| series | The Journal of Critical Care Medicine |
| spelling | doaj.art-24237396815d4d49830827ceb177d5822023-12-03T06:45:18ZengSciendoThe Journal of Critical Care Medicine2393-18172021-11-018161310.2478/jccm-2021-0024The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: A Literature ReviewTilinca Mariana Cornelia0Gliga Maximilian Cosma1Varga Andreea2George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Targu Mures, RomaniaMures County Hospital, Targu Mures, RomaniaGeorge Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Targu Mures, RomaniaDiabetic individuals are considered a vulnerable population during the COVID-19 Pandemic, and several studies noted worse outcomes, including death, among those who get infected. Diabetic emergencies, such as ketoacidosis (DKA), are common and potentially life-threatening conditions in uncontrolled patients. While the pathophysiological background of the relationship between COVID-19 and DKA is not fully understood, early reports available so far indicate that patients with pre-existing diabetes who get infected with the SARS-CoV 2 virus are at higher risk of DKA. It was also suggested that DKA is a poor prognostic sign for infected patients, these being at higher risk of developing worse forms of COVID-19 disease and having high mortality. Therefore, healthcare personnel dealing with such patients face a considerable challenge, as the correct and safe emergency management of such cases is far from established. This article aimed to conduct a study that reviews the current published data available about patients with DKA and COVID-19.https://doi.org/10.2478/jccm-2021-0024covid-19diabetesketoacidosispandemicpathogenesis |
| spellingShingle | Tilinca Mariana Cornelia Gliga Maximilian Cosma Varga Andreea The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: A Literature Review The Journal of Critical Care Medicine covid-19 diabetes ketoacidosis pandemic pathogenesis |
| title | The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: A Literature Review |
| title_full | The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: A Literature Review |
| title_fullStr | The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: A Literature Review |
| title_full_unstemmed | The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: A Literature Review |
| title_short | The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: A Literature Review |
| title_sort | pathophysiology and management of diabetic ketoacidosis in covid 19 patients a literature review |
| topic | covid-19 diabetes ketoacidosis pandemic pathogenesis |
| url | https://doi.org/10.2478/jccm-2021-0024 |
| work_keys_str_mv | AT tilincamarianacornelia thepathophysiologyandmanagementofdiabeticketoacidosisincovid19patientsaliteraturereview AT gligamaximiliancosma thepathophysiologyandmanagementofdiabeticketoacidosisincovid19patientsaliteraturereview AT vargaandreea thepathophysiologyandmanagementofdiabeticketoacidosisincovid19patientsaliteraturereview AT tilincamarianacornelia pathophysiologyandmanagementofdiabeticketoacidosisincovid19patientsaliteraturereview AT gligamaximiliancosma pathophysiologyandmanagementofdiabeticketoacidosisincovid19patientsaliteraturereview AT vargaandreea pathophysiologyandmanagementofdiabeticketoacidosisincovid19patientsaliteraturereview |